Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

NCT00211198

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope National Medical Center Duarte, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

The University of Iowa Iowa City, Iowa, United States

New England Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

NCT00050999

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 35 locations

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

NCT00051012

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 34 locations

View Trial Details

Completed

Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00026910

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

NCT00001430

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

NCT00001249

Conditions: Diabetes Mellitus, Insulin-Dependent, 10, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines

NCT00001571

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +21 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

NCT00015665

Conditions: Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

NCT00001237

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

NCT00001301

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions